Medication Card contribution guide
Joshua Yu March 17, 2025-
Medications can be found in this page here and are also accessible through popups
-
The goal is to provide cards that are succinct and relevant, not a deep dive – the user can look at the monograph if needed for more detail
-
As such, there's a relatively standardized structure/format for medications
- The editors will deal with the categories section
- Monographs will be statically hosted and linked. Include a link for the monograph in your draft file so it can be uploaded to the site (it should come from a government site!!)
# All sections accept HTML aside from the pearls, which accepts markdown format
[]
# [medname] must be formatted as {generic (hyphenate if combination)} with {_route} if dramatically different from oral.
# for example: [budesonide_inhaler] because the oral form is used for EoE.
# similarly, [fluticasone-furoate_inhaler] - note the hyphenation used between the drug combos.
= false # if false, the medication card will be rendered with a WIP sign
= ["testcategory"] # check with the editors for the proper category
= ["brandnameA", "brandnameB"]
= [
{ = "ON", = "~$X CAD / Ymg tab" },
{ = "BC", = "~$X CAD / Ymg tab" },
]
= [
{ = "ON", = "enter details" }, # ie. ODB
{ = "BC", = "enter details" },
]
= "yes" # only 'yes' or 'no' or 'both' allowed
= "Insert MoA" # should be BRIEF
= "~X hours"
= "Optional" # how long it takes for the medication to have its intended or maximal effect
= "Xmg tab; Xmg/ml liq" # include doses available for each route ie. "10/20mg tab; 2.5mg/ml liq"
= [
{ = "diseaseA", = "Zmg OD", = "ages 3-11" }, # ages should be listed as "ages X-Y", or "ages ≥X"
{ = "diseaseA", = "Zmg OD", = "ages ≥12; CrCl < 30" }, # separate different notes with semi-colon
{ = "diseaseB", = "Zmg BID", = "ages ≥18; >25kg" }, # just list weights out
]
= "insert age group" # just list the ages it has been used in; this is a broad overview. you'll go into the specific ages for separate indications in the doses section
= "insert information, can link to data/links if need be"
= "insert"
= "insert" # common is ≥1%; if severe list below instead; if possible list out drug vs placebo rates from the monograph, ie. "Drowsiness 3-9%[D], 2-5%[P];"
= "insert" # list the probability for these
= [
"/monographs/example_2025_1.pdf",
] # Filenames should be formatted as: genericname_2016_1, where the year is of the last revision and the last number is if there are multiple monographs that year for that drug
= "" # ie: "AR-allergic rhinitis; CRS-chronic rhinosinusitis; AI-adrenal insufficiency"
= [
"Insert pearl here",
]
Here is an example:
[]
= false
= ["2G antihistamine"]
= ["Blexten"]
= [{ = "ON", = "~$1.1 CAD / 20mg tab" }]
= [{ = "ON", = "ODB" }]
= "no"
= "2nd gen H1 receptor antagonist"
= "~15 hours"
= "~1h, rapid absorption"
= "10/20mg tab, 2.5mg/ml liq (uncommon)"
= [
{ = "CSU, AR", = "20mg PO OD to QID", = "ages ≥12" },
{ = "CSU, AR", = "10mg PO OD to QID", = "ages 4-11" },
]
= "ages ≥4"
= "Avoid (not enough data)"
= "Hypersensitivity, QT prolongation or history of torsades"
= "QT prolongation (at 100mg ODx4, max mean increase 6ms); drowsiness/headache ~4%[D], ~3%[P]; abdo pain 3%[D], 3%[P]"
= "Torsades (extremely rare; only 1 case reported in monograph post-market reactions)"
= ["/monographs/bilastine_2021_1.pdf"]
= "CSU-chronic spontaneous urticaria; AR-allergic rhinitis"
= [
"Theoretically does not cross BBB; less sedating than other AHs",
"No renal adjustments needed; minimal data with hepatic impairment but not expected to cause issues",
"Going beyond OD is technically off-label",
"Take without food or juice otherwise absorption impaired",
]
How it'll actually look:
Bilastine
Brand Names: Blexten
Routes: 10 or 20mg tab, 2.5mg/ml liq (uncommon)
MoA: 2nd gen H1 receptor antagonist
Half-life: ~15 hours
Time to peak action: ~1h, rapid absorption
Doses:
- CSU, AR:
- 20mg PO OD to QID (ages ≥12)
- 10mg PO OD to QID (ages 4-11)
Cost: ~$1.1 CAD / 20mg tab (ON)
Coverage: ON (ODB)
Age Group: ages ≥4
Pregnancy: Avoid (not enough data)
Contraindications: Hypersensitivity, QT prolongation or history of torsades
Common SEs: QT prolongation (at 100mg ODx4, max mean increase 6ms); drowsiness/headache ~4%[D], ~3%[P]; abdo pain 3%[D], 3%[P]
Severe SEs: Torsades (extremely rare; only 1 case reported in monograph post-market reactions)
Monograph Links:
Pearls
Theoretically does not cross BBB; less sedating than other AHs
No renal adjustments needed; minimal data with hepatic impairment but not expected to cause issues
Going beyond OD is technically off-label
Take without food or juice otherwise absorption impaired